These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 19775658)
41. [Pathology of the ovarian tumors, with special reference to comparison between WHO's classification and that of Japan Society of Obstetrics and Gynecology (author's transl)]. Namiki T Rinsho Byori; 1980; 28(6):557-63. PubMed ID: 7411973 [No Abstract] [Full Text] [Related]
42. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer. Kuschel B; Lux MP; Goecke TO; Beckmann MW Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253 [TBL] [Abstract][Full Text] [Related]
43. Ovarian cancer: pathology, biology, and disease models. Rosen DG; Yang G; Liu G; Mercado-Uribe I; Chang B; Xiao XS; Zheng J; Xue FX; Liu J Front Biosci (Landmark Ed); 2009 Jan; 14(6):2089-102. PubMed ID: 19273186 [TBL] [Abstract][Full Text] [Related]
48. Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data. Vang R; Shih IeM; Salani R; Sugar E; Ayhan A; Kurman RJ Am J Surg Pathol; 2008 Nov; 32(11):1667-74. PubMed ID: 18769340 [TBL] [Abstract][Full Text] [Related]
49. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148 [TBL] [Abstract][Full Text] [Related]
50. Subclassification of ovarian cancer based on pathology and genetics. Prat J Eur J Cancer; 2009 Sep; 45 Suppl 1():427-8. PubMed ID: 19775658 [No Abstract] [Full Text] [Related]